A detailed history of Beck Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Beck Capital Management, LLC holds 1,966 shares of VRTX stock, worth $924,727. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,966
Previous 1,887 4.19%
Holding current value
$924,727
Previous $788,000 16.88%
% of portfolio
0.28%
Previous 0.25%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $31,031 - $38,356
79 Added 4.19%
1,966 $921,000
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $1,223 - $1,338
3 Added 0.16%
1,887 $788,000
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $2,401 - $2,874
-7 Reduced 0.37%
1,884 $766,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $7,101 - $7,611
21 Added 1.12%
1,891 $657,000
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $71,373 - $79,883
-227 Reduced 10.82%
1,870 $658,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $37,386 - $42,649
-132 Reduced 5.92%
2,097 $660,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $14,859 - $16,716
-52 Reduced 2.28%
2,229 $643,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $11,774 - $13,137
43 Added 1.92%
2,281 $660,000
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $525,840 - $654,726
2,238 New
2,238 $631,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Beck Capital Management, LLC Portfolio

Follow Beck Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Capital Management, LLC with notifications on news.